BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 19304921)

  • 1. Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients.
    Liang P; Wang Y; Yu X; Dong B
    Radiology; 2009 Jun; 251(3):933-40. PubMed ID: 19304921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: analysis of major complications in 693 patients].
    Wang XH; Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Liu FY
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):945-9. PubMed ID: 23336384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients.
    Lorentzen T; Skjoldbye BO; Nolsoe CP
    Ultraschall Med; 2011 Oct; 32(5):492-6. PubMed ID: 21259183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications after percutaneous saline-enhanced radiofrequency ablation of liver tumors: 3-year experience with 336 patients at a single center.
    Giorgio A; Tarantino L; de Stefano G; Coppola C; Ferraioli G
    AJR Am J Roentgenol; 2005 Jan; 184(1):207-11. PubMed ID: 15615976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y
    Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study.
    Livraghi T; Solbiati L; Meloni MF; Gazelle GS; Halpern EF; Goldberg SN
    Radiology; 2003 Feb; 226(2):441-51. PubMed ID: 12563138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of microwave ablation for liver tumors: results of a multicenter study.
    Livraghi T; Meloni F; Solbiati L; Zanus G;
    Cardiovasc Intervent Radiol; 2012 Aug; 35(4):868-74. PubMed ID: 21833809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events during radiofrequency treatment of 582 hepatic tumors.
    de Baère T; Risse O; Kuoch V; Dromain C; Sengel C; Smayra T; Gamal El Din M; Letoublon C; Elias D
    AJR Am J Roentgenol; 2003 Sep; 181(3):695-700. PubMed ID: 12933462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-guided percutaneous microwave ablation of adrenal metastasis: preliminary results.
    Wang Y; Liang P; Yu X; Cheng Z; Yu J; Dong J
    Int J Hyperthermia; 2009; 25(6):455-61. PubMed ID: 19925324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of malignant liver tumors using microwave and radiofrequency ablation].
    Popescu I; Sîrbu-Boeţi MP; Tomulescu V; Ciurea S; Boroş M; Hrehoreţ D; Jemna C
    Chirurgia (Bucur); 2005; 100(2):111-20. PubMed ID: 15957451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-guided percutaneous radiofrequency ablation and incidence of post-radiofrequency ablation syndrome: prospective survey.
    Wah TM; Arellano RS; Gervais DA; Saltalamacchia CA; Martino J; Halpern EF; Maher M; Mueller PR
    Radiology; 2005 Dec; 237(3):1097-102. PubMed ID: 16304121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency and microwave tumor ablation in patients with implanted cardiac devices: is it safe?
    Skonieczki BD; Wells C; Wasser EJ; Dupuy DE
    Eur J Radiol; 2011 Sep; 79(3):343-6. PubMed ID: 20434862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microwave ablation with cooled-tip electrode for liver cancer: an analysis of 160 cases.
    Zhang X; Zhou L; Chen B; Hu S; Wachtel MS; Frezza EE
    Minim Invasive Ther Allied Technol; 2008; 17(5):303-7. PubMed ID: 18942003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major complications of ultrasound-guided percutaneous radiofrequency ablations for liver malignancies: single center experience.
    Chen TM; Huang PT; Lin LF; Tung JN
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e445-50. PubMed ID: 17683478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver cancer: increased microwave delivery to ablation zone with cooled-shaft antenna--experimental and clinical studies.
    Kuang M; Lu MD; Xie XY; Xu HX; Mo LQ; Liu GJ; Xu ZF; Zheng YL; Liang JY
    Radiology; 2007 Mar; 242(3):914-24. PubMed ID: 17229876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of thermal ablation of hepatic tumours: comparison of radiofrequency and microwave ablative techniques.
    Ding J; Jing X; Liu J; Wang Y; Wang F; Wang Y; Du Z
    Clin Radiol; 2013 Jun; 68(6):608-15. PubMed ID: 23399463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness.
    Sartori S; Tombesi P; Macario F; Nielsen I; Tassinari D; Catellani M; Abbasciano V
    Radiology; 2008 Aug; 248(2):670-9. PubMed ID: 18519740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microwave ablation therapy: clinical utility in treatment of pulmonary metastases.
    Vogl TJ; Naguib NN; Gruber-Rouh T; Koitka K; Lehnert T; Nour-Eldin NE
    Radiology; 2011 Nov; 261(2):643-51. PubMed ID: 22012906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound guided percutaneous microwave ablation for small renal cancer: initial experience.
    Liang P; Wang Y; Zhang D; Yu X; Gao Y; Ni X
    J Urol; 2008 Sep; 180(3):844-8; discussion 848. PubMed ID: 18635230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.